Here’s what was new in the world of medical device suppliers during the week of January 13.
Capillary Biomedical has raised $2.9 million in a seed financing and hopes to bring its technology to market in 2019.
The company’s chemically reactive coating could ensure a contaminant-free environment for nitric oxide tubing, a lifesaving drug used to treat oxygen-deprived newborns.
A Cleveland Clinic doctor talks about his hope for the future of better in-patient monitoring on the general care floors, and how an ongoing global trial using a Medtronic device could be a big step toward making that vision a reality.
Demand for port access needles, midline and extended-dwell peripheral catheters, ultrasound systems for vascular access, and catheter securement devices is driving growth.
MD&M Minneapolis is the place to see the latest and greatest offerings from medtech industry suppliers and service providers, and you'll definitely want to check out these five products at the show.
In a new warning letter to Magellan Diagnostics, FDA accused the company of several legal violations, including marketing significantly modified versions of two of its blood lead testing systems without regulatory clearance and failing to submit medical device reports after learning of faulty blood test results.
Catheter-based delivery systems have helped push heart valve replacement technologies forward. What's next on the horizon?
The race is on for medical device manufacturers to prepare for compliance with new global standards intended to prevent tubing misconections expected to be published in 2016 and 2017.
Interrad Medical says its nontraumatic securement device can help reduce problems such as migration and dislodgement in hundreds of millions of catheter lines.
The increasing move to minimally invasive surgical procedures has motivated medical tubing and extrusion experts to test the boundaries of miniaturization.
Developing balloon catheters with lower profiles will be key to advancing transcatheter aortic valve replacement systems.
Parker Hannifin is opening a new innovation center in Ohio and collaborating with the Cleveland Clinic and the University of Akron to develop and prototype new uses of medical polymers.